Pharmacy Consulting

Pharmacy Healthcare Solutions Inc. (PHSI) consults with pharmaceutical manufacturers, PBMs, pharmacies (retail, specialty, mail service, LTC, and hospital outpatient), and technology companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSI with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.

News & Events

PHSI to Attend NACDS Total Store Expo

PHSI President Tim Kosty, Vice President Don Dietz, Consultants and Partners Ann Johnson and Melissa Krause, and Director of Business Development Fred Hamlin will be attending the 2019 NACDS Total Store Expo in Boston, Massachusetts on August 24-26. PHSI will have an exhibit set up at booth number 1618. If you would like to schedule a Read More →

ComputerTalk for the Pharmacist July/August 2019

PHSI Consultant and Partner Ann Johnson contributed to the July/August 2019 edition of ComputerTalk for the Pharmacist. In the Viewpoints article, Ann discusses the biosimilar four-character suffix assignments and the impact of these suffixes on product appearance in EHRs, pharmacy management systems, and wholesaler ordering systems. Click here to read Ann’s article entitled “Impact of Read More →

Tim Kosty and Melissa Krause Attending PBGH Annual Symposium

PHSI President Tim Kosty and Consultant, PHSI Partner Melissa Krause will be attending the Pittsburgh Business Group on Health (PBGH) Annual Health Care Symposium on Thursday, September 12, 2019 in Pittsburgh, PA. To learn more about the event and PBGH, visit If you would like to meet with Tim and Melissa at the Symposium, Read More →

Latest from the Blog

Update: Mandating Price Reporting in Prescription Drug Advertisements

In May 2019, PHSI published a blog discussing the Department of Health and Human Services (HHS) agreement to move forward with one of the initiatives of the Trump Administration’s “American Patients First” blueprint. Part of the “American Patients First” initiative  would require drug manufacturers to report list prices on prescription drug advertisements, in hopes that Read More →

Medicaid Rebates and the Impact of Authorized Generics

Excluding Authorized Generics from Brand Drug AMP Calculations The Office of Inspector General (OIG) published a review in April 2019 assessing how excluding authorized generics from average manufacturer price (AMP) calculations would impact Medicaid drug rebates. This review was prompted by a 2017 HHS Budget Brief, which stated that excluding authorized generics could save Medicaid Read More →

Cannabidiol (CBD) Oil in Pharmacy

At the end of March 2019, CVS and Walgreens announced that they will start selling over the counter topical products containing CBD in specific states only, due to the legalization of CBD in those states. Cannabidiol, better known by the abbreviation CBD, is one of the most talked about ingredients today. CBD is a non-psychoactive Read More →